{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T04:34:28Z","timestamp":1783139668422,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.beem.2012.01.004","type":"journal-article","created":{"date-parts":[[2012,5,31]],"date-time":"2012-05-31T02:31:47Z","timestamp":1338431507000},"page":"517-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Hypoparathyroidism"],"prefix":"10.1016","volume":"26","author":[{"given":"Hafsah","family":"Al-Azem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2012.01.004_bib1","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1002\/jbmr.483","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, targetorgan involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"Journal of Bone & Mineral Research"},{"key":"10.1016\/j.beem.2012.01.004_bib2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1056\/NEJMcp0803050","article-title":"Clinical practice: hypoparathyroidism","volume":"359","author":"Shoback","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.01.004_bib3","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM200012213432508","article-title":"Hyperparathyroid and hypoparathyroid disorders","volume":"343","author":"Marx","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.01.004_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.amjsurg.2008.07.022","article-title":"Reoperative parathyroidectomy in 228 patients during the era of minimal-access surgery and intraoperative parathyroid hormone monitoring","volume":"196","author":"Richards","year":"2008","journal-title":"American Journal of Surgery"},{"key":"10.1016\/j.beem.2012.01.004_bib5","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0140-6736(07)61601-8","article-title":"Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes","volume":"370","author":"Kobrynski","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.01.004_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000095944","article-title":"Parathyroid development and the role of tubulin chaperone E.","volume":"358","author":"Parvari","year":"2007","journal-title":"Hormone Research"},{"key":"10.1016\/j.beem.2012.01.004_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/adc.66.2.193","article-title":"A new syndrome of congenital hypoparathyroidism, severe growth failure, and dysmorphic features","volume":"66","author":"Sanjad","year":"1991","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.beem.2012.01.004_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng1194-303","article-title":"Autosomal dominant hypocalcemia caused by a calcium-sensing receptor gene mutation","volume":"8","author":"Pollak","year":"1994","journal-title":"Nature Genetics"},{"key":"10.1016\/j.beem.2012.01.004_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2012.01.004_bib10","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJMra030158","article-title":"Autoimmune polyendocrine syndromes","volume":"350","author":"Eisenbarth","year":"2004","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.01.004_bib11","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(00)04254-9","article-title":"Genetic developments in hypoparathyroidism","volume":"357","author":"Thakkar","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.beem.2012.01.004_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ecl.2009.01.001","article-title":"Anti-Parathyroid and Anti-Calcium Sensing Receptor Antibodies in Autoimmune Hypoparathyroidism","volume":"38","author":"Brown","year":"2009","journal-title":"Endocrinology & Metabolism Clinics of North America"},{"key":"10.1016\/j.beem.2012.01.004_bib13","first-page":"675","article-title":"Endocrine manifestations of stimulatory G protein alpha-subunit mutations and the role of genomic imprinting","volume":"22","author":"Weistein","year":"2001","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.beem.2012.01.004_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-0-387-77576-0_3","article-title":"The GNAS locus and pseudohypoparathyroidism","volume":"626","author":"Bastepe","year":"2008","journal-title":"Advances in Experimental Medicine & Biology"},{"key":"10.1016\/j.beem.2012.01.004_bib15","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.beem.2012.01.004_bib16","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1007\/s00198-009-1149-x","article-title":"Therapy of hypoparathyroidism with intact parathyroid hormone","volume":"21","author":"Rubin","year":"2010","journal-title":"Osteoporosis International"},{"key":"10.1016\/j.beem.2012.01.004_bib17","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.beem.2012.01.004_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2009.09.020","article-title":"Three dimensional cancellous bone structure in hypoparathyroidism","volume":"46","author":"Rubin","year":"2010","journal-title":"Bone"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12000164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X12000164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:46:01Z","timestamp":1761497161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X12000164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1521690X12000164"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2012.01.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoparathyroidism","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2012.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}